Children Rx ADHD Drugs 7.4 times increased risk of sudden death
But FDA says keep taking the "medicines."
But FDA says keep taking the "medicines."
Among the most damaging scientific evidence against the use of antipsychotic drugs is empirical evidence that they cause brain damage.
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
Psychiatry’s leadership is scrambling and fumbling in its effort to explain why it’s collusion with industry for pay is okay.
This is a result of public awareness–thanks to information uncovered during litigation, by Sen. Charles Grassley’s investigative team, by whistleblowers, and the press!
Two news reports: Alaska Supreme Court decision and a JAMA report confirms that risk of violence among schizophrenia patients "was mostly confined to patients with substance abuse comorbidity."
The Japanes Ministry of Health, Labor and Welfare has investigated news reports about antidepressant users "who developed increased feelings of hostility or anxiety, and have even committed sudden acts of violence against others."
Colonel Coots: "It is a significant breach of academic protocol. It’s a breach of trust."
Two important analyses in Open Medicine , a peer-reviewed, independent, open-access journal, focus on methodological flaws in data analysis of randomized drug trials.
"William Weeks, MD a professor of psychiatry and community and family medicine is facing federal conflict of interest charges" involving contract between the Veterans Affairs department and Dartmouth.
Sen. Charles Grassley’s focused investigation is clearly aimed at cleansing fraudulent, industry-crafted promotional pieces that have made a mockery of evidence-based clinical practice in psychiatry.